589
Views
14
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Non-psoriatic dermatologic uses of monoclonal antibody therapy

, &
Pages 319-327 | Received 26 Feb 2009, Accepted 10 Mar 2009, Published online: 02 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melody Maarouf, Ashley K. Clark, Dylan E. Lee & Vivian Y. Shi. (2018) Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. Journal of Dermatological Treatment 29:5, pages 441-449.
Read now

Articles from other publishers (13)

Jinjing Shen, Weishe Zhang & Xiaoe Jiang. (2019) Pyoderma gangrenosum after cesarean section treated with skin graft. Medicine 98:18, pages e15380.
Crossref
Natalie Ong, Erin McMeniman, Peter Pillans & H Peter Soyer. (2015) A clinical audit of high‐cost and off‐label drug use in dermatology. Australasian Journal of Dermatology 58:1, pages 30-34.
Crossref
Bryan Murphy, Graham Morrison & Pat Podmore. (2015) Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis. International Journal of Colorectal Disease 30:8, pages 1139-1140.
Crossref
M. Augustin. (2013) Sachgerechte Off-label-Verordnung in der PraxisAppropriate off-label prescription in practice. Der Hautarzt 64:10, pages 728-735.
Crossref
Kata Filkor, Zolt?n Heged?s, Andr?s Sz?sz, Vilmos Tubak, Lajos Kem?ny, ?va Kondorosi & Istv?n Nagy. (2013) Genome Wide Transcriptome Analysis of Dendritic Cells Identifies Genes with Altered Expression in Psoriasis. PLoS ONE 8:9, pages e73435.
Crossref
I. Sick, B. Trautner & T. Ruzicka. (2011) Chirurgische Therapie beim Pyoderma gangraenosumSurgical management of Pyoderma gangrenosum. Der Hautarzt 63:7, pages 577-583.
Crossref
P. Al Ghazal & J. Dissemond. (2012) Multilokuläres Pyoderma gangraenosum nach UterusresektionMultilocular pyoderma gangrenosum after uterus resection. Der Chirurg 83:3, pages 254-257.
Crossref
Jing Yu, Dhaval R. Kalaria & Yogeshvar N. Kalia. (2011) Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. Journal of Controlled Release 156:1, pages 53-59.
Crossref
Bodi Zhang, Konstantinos-Dionysios Alysandratos, Asimenia Angelidou, Shahrzad Asadi, Nikolaos Sismanopoulos, Danae-Anastasia Delivanis, Zuyi Weng, Alexandra Miniati, Magdalini Vasiadi, Alexandra Katsarou-Katsari, Benchun Miao, Susan E. Leeman, Dimitrios Kalogeromitros & Theoharis C. Theoharides. (2011) Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis. Journal of Allergy and Clinical Immunology 127:6, pages 1522-1531.e8.
Crossref
M. Luisa Pérez-Cotapos S, M. Soledad Zegpi T & M. Luisa Sáenz De Santa María. (2011) Dermatitis atópica. Revista Médica Clínica Las Condes 22:2, pages 197-203.
Crossref
Uwe Wollina & Gunter Haroske. (2011) Pyoderma gangraenosum. Current Opinion in Rheumatology 23:1, pages 50-56.
Crossref
I. Sick & T. Ruzicka. (2011) Pyoderma gangraenosumPyoderma gangrenosum. Journal f?r ?sthetische Chirurgie 4:1, pages 7-11.
Crossref
Francesco Baglieri & Giovanni Scuderi. (2010) THERAPEUTIC HOTLINE: Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report. Dermatologic Therapy 23:5, pages 541-543.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.